Medline Inc. Class A Common Stock (MDLN) — Working Capital to Net Assets Ratio
Medline Inc. Class A Common Stock (MDLN) has a Working Capital to Net Assets ratio of 44.7% as of March 2026. Working capital of $8.64 Billion (current assets of $11.18 Billion minus current liabilities of $2.54 Billion) is measured against net assets of $19.35 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial agility of Medline Inc. Class A Common Stock to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Medline Inc. Class A Common Stock Working Capital to Net Assets (2023–2025)
This chart shows how Medline Inc. Class A Common Stock's Working Capital to Net Assets ratio has evolved across 3 annual periods from 2023 to 2025. As of March 2026, the ratio stands at 44.7%, reflecting working capital of $8.64 Billion against net assets of $19.35 Billion USD. See MDLN cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Medline Inc. Class A Common Stock (2023–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Medline Inc. Class A Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market cap of Medline Inc. Class A Common Stock.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 42.5% | $8.19 Billion | $19.29 Billion | $10.68 Billion | $2.49 Billion | ▲ +7.2 pp |
| 2024 | 35.3% | $5.83 Billion | $16.52 Billion | $8.27 Billion | $2.44 Billion | ▼ -4.0 pp |
| 2023 | 39.3% | $6.68 Billion | $16.98 Billion | $8.81 Billion | $2.13 Billion | — |